Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2000
11/09/2000WO2000031306A3 Multiplex amplification of short tandem repeat loci
11/09/2000WO2000029830A9 Refractometer and method for qualitative and quantitative measurements
11/09/2000WO2000029617A3 Water-soluble luminescent quantum dots and bioconjugates thereof
11/09/2000WO2000029564A3 Human glycine transporter type 2
11/09/2000WO2000028813A9 Treatment of myelogenous leukemia
11/09/2000WO2000028034A3 Cytokine signal regulators
11/09/2000WO2000027999A9 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices
11/09/2000WO2000024780A3 Compositions and methods for treating polycystic kidney disease
11/09/2000WO2000024765A3 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000WO2000021996A3 Methods and compositions for inhibiting neoplastic cell growth
11/09/2000WO2000020638A3 Methods and compositions for the diagnosis and therapy of prostate cancer
11/09/2000WO2000015826A3 Leptin induced genes
11/09/2000WO2000015785A3 GENE MODIFICATION IN THE GENE FOR THE DIE Gβ3-SUB-UNIT OF HUMAN G-PROTEIN
11/09/2000WO2000008209A3 Nucleic acids encoding human tbc-1 protein and polymorphic markers thereof
11/09/2000WO2000006737A8 Streptococcus pneumoniae proteins and nucleic acid molecules
11/09/2000WO2000004050A3 Neurotrophic growth factor
11/09/2000WO2000001349A3 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same
11/09/2000WO1999055868A3 Fizz proteins
11/09/2000DE19963029A1 Process for measuring carbon monoxide gas-material exchange processes and transpiration of intact plants at a natural site comprises measuring carbon dioxide and water concentrations
11/09/2000DE19920592A1 Method to automatically recognise fibrous material or mixtures; involves using near infrared spectroscopy to study unmodified material sample, and using neural network to evaluate results
11/09/2000DE19920219A1 Process for assuring the quality of the spot-welded joints between two workpieces comprises subjecting the welded joint to heat, and obtaining temperature-dependent characteristic line on the welded joint and comparing with reference value
11/09/2000DE19919472A1 Vorrichtung und Verfahren zur Detektion von Ammoniak Device and method for the detection of ammonia
11/09/2000DE19919121A1 Multimeric cytomegalovirus antigen useful as an immunoassay reagent, and which comprises at least two p52 peptide sequences
11/09/2000DE19918442A1 Färbeautomat zum Einfärben von Objekten zur mikroskopischen Untersuchung Stainer for coloring objects for microscopic examination
11/09/2000DE19917975A1 Characterization of filler dispersion in polymers uses surface roughness measurements of section displayed as surface topography
11/09/2000DE19911753C1 Water quality parameter determination device for water circulating in heat generating or distributing installations comprises bypass pipe containing flow sensors and components for cleaning and conditioning them
11/09/2000DE19841301A1 In situ sampling system for ground water comprises laying slightly sloping collecting pipes at different levels in formation, collected water being fed to subterranean chamber or sampled directly by probes in bores at ends of pipes
11/09/2000CA2742143A1 2-3-dihydroxypropyl 12-(7-nirobenzo[1,2,3]oxadiazol-4-ylamino)dodecanoates and a process for the preparation thereof
11/09/2000CA2373021A1 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000CA2373018A1 Novel cellular regulation factor tto 20
11/09/2000CA2372946A1 Asialocytokines and treatment of liver disease
11/09/2000CA2372923A1 Dna encoding snorf36a and snorf36b receptors
11/09/2000CA2372190A1 Methods for the treatment of neuronal atrophy-associated dementia
11/09/2000CA2372022A1 Traf5 knockout mouse
11/09/2000CA2371946A1 Expression of heterologous genes from an ires translational cassette in retroviral vectors
11/09/2000CA2371768A1 Method of screening for drugs useful in treating alzheimer's disease
11/09/2000CA2371596A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof
11/09/2000CA2371579A1 System for control of blood processor
11/09/2000CA2371577A1 Forms of prostate specific antigen (psa) specific for benign prostatic hyperplasia (bph) and methods of using such
11/09/2000CA2371421A1 Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumour therapies
11/09/2000CA2371260A1 Materials and methods relating to neuronal development
11/09/2000CA2371032A1 Neisseria genomic sequences and methods of their use
11/09/2000CA2370821A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
11/09/2000CA2370587A1 Use of heparin-binding antagonists in the inhibition of bradykinin release
11/09/2000CA2370495A1 Peptides from the tt virus sequence and monospecific antibodies binding to the tt virus
11/09/2000CA2370427A1 Laboratory examination of a body fluid or tissue sample
11/09/2000CA2370304A1 Specific antibodies and antibody fragments for tgf.beta.1
11/09/2000CA2370261A1 Process to create biomolecule arrays on metal surfaces
11/09/2000CA2370252A1 Cancer treatment with endothelin receptor antagonists
11/09/2000CA2370177A1 Methods for the identification of compounds for the treatment of alzheimer's disease
11/09/2000CA2370119A1 Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus
11/09/2000CA2370117A1 Method of detection of cytochrome b mutations in funghi leading to resistance against anti-fungal agents
11/09/2000CA2370111A1 Optical probes and assays
11/09/2000CA2369830A1 Methods, compositions and kits for biological indicator of sterilization
11/09/2000CA2369371A1 Death domain containing receptor 5
11/09/2000CA2369363A1 Device for rapid dna sample processing with integrated liquid handling, thermocycling, and purification
11/09/2000CA2365440A1 Human ion channel proteins
11/09/2000CA2365278A1 Tumour-associated antigen
11/09/2000CA2340905A1 Method for detecting biological agents
11/08/2000EP1050758A1 Methods of diagnosing or treating neuropsychiatric diseases on basis of increased cerebrospinal fluid levels of neurotrophin 3
11/08/2000EP1050757A1 Methods of diagnosing or treating Alzheimer's disease on basis of increased cerebrospinal fluid levels of nerve growth factor
11/08/2000EP1050753A2 System and method for sensing and controlling beverage quality
11/08/2000EP1050588A1 A device for performing an assay, use of a membrane in the manufacture of said device, kit comprising said device and method for the detection of an analyte using such device
11/08/2000EP1050581A1 Method for detecting acetyltransferase and deacetylase activities and method for screening inhibitors or accelerators of these enzymes
11/08/2000EP1049934A1 Specific antibodies to kringle 5 of apolipoprotein a and methods of use therefor
11/08/2000EP1049933A1 Measurement of hydride using chemiluminescent acridinium compounds
11/08/2000EP1049932A1 Detection system using liposomes and signal modification
11/08/2000EP1049931A1 Sensor
11/08/2000EP1049919A1 Method for differentiation of nucleated red blood cells
11/08/2000EP1049808A1 Force discrimination assay
11/08/2000EP1049807A1 Microparticles with multiple fluorescent signals
11/08/2000EP1049802A1 Fluorimetric detection system of a nucleic acid
11/08/2000EP1049799A1 Antimicrobial compounds
11/08/2000EP1049796A1 Methods for the simultaneous identification of novel biological targets and lead structures for drug development
11/08/2000EP1049787A1 Multipurpose antibody derivatives
11/08/2000EP1049781A1 Human chemokine and its use for detection and treatment of breast disease
11/08/2000EP1049780A1 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/08/2000EP1049776A1 Phagocytosis genes and uses thereof
11/08/2000EP1049744A1 Asymmetric cyanine dye quenchers
11/08/2000EP1049489A1 Agent capable of modulating a glycosphingolipid-associated activity thus affecting an immune disorder
11/08/2000EP1049488A1 METHOD OF AND COMPOSITIONS FOR IMMUNIZATION WITH THE $i(PSEUDOMONAS) V ANTIGEN
11/08/2000EP1049475A1 KINESIN MOTOR MODULATORS DERIVED FROM THE MARINE SPONGE $i(ADOCIA)
11/08/2000EP1049465A1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer
11/08/2000EP0936951A4 Methods for producing low binding surfaces
11/08/2000EP0812422B1 Process and compounds for use in detecting analytes by measurement of residual magnetism, and the use of the said compounds
11/08/2000EP0721512B1 Quick biochemical oxygen demand test and apparatus for the same
11/08/2000EP0687180B1 Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/tyrosinase peptide antigens
11/08/2000EP0655089B1 Effects of actin filaments on fibrin clot structure and lysis
11/08/2000EP0649530B1 CHEMILUMINESCENT ASSAY FOR dsDNA ANTIBODIES
11/08/2000EP0641440B1 Reagents and methods for the quantification of total doxepins in biological fluids
11/08/2000EP0636029B1 Antibodies specific for carcinoma-associated antigens
11/08/2000EP0635132B1 Broadly reactive opsonic antibodies that react with common staphylococcal antigens
11/08/2000EP0633944B1 Method of multiplex ligase chain reaction
11/08/2000EP0619020B1 Determination of tricyclic antidepressant drugs in the presence of interfering substances
11/08/2000CN1272886A Polynucleotide encoding polypeptide having heparanase activity and expression of same in transduced cells
11/08/2000CN1272883A Adipocyte-specific protein homologs
11/08/2000CN1272876A Gram negative coccoid bacterium
11/08/2000CN1272627A Device for enzymoimmunodiacolation detection and its production method
11/08/2000CN1272549A GFP-TNF-alpha fusion protein prokaryotic expression system construction and its product and application
11/08/2000CN1058297C Clone of nephropathy syndrome hemorrhagic fever Hantan virus gene manification product and its application